Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 19Gynecologic 6Head & Neck 5Thoracic 4Breast 3Other solid neoplasm 1Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × TP protocol × Breast × Clear all
NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

RenJi Hospital

Phase 3 Recruiting
762 enrolled
Breast

Carcinoma, Ductal, Breast

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Sichuan Provincial People's Hospital

Phase 2 Unknown
100 enrolled
Breast

Breast Neoplasms

NCT01216111 2020-05-19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Fudan University

Phase 3 Completed
647 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡